Compare SRTA & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SRTA | CCAP |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance: Consumer Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.4M | 492.4M |
| IPO Year | N/A | N/A |
| Metric | SRTA | CCAP |
|---|---|---|
| Price | $4.65 | $12.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $7.63 | ★ $16.33 |
| AVG Volume (30 Days) | ★ 807.8K | 173.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.11% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $37.89 | N/A |
| Revenue Next Year | $14.33 | N/A |
| P/E Ratio | ★ $9.88 | $14.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.85 | $12.56 |
| 52 Week High | $6.02 | $17.97 |
| Indicator | SRTA | CCAP |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 34.97 |
| Support Level | $4.26 | $12.56 |
| Resistance Level | $5.15 | $14.70 |
| Average True Range (ATR) | 0.24 | 0.44 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 51.65 | 12.75 |
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.